Raju Kucherlapati, PhD

KEW Founder, Board Member

Founder and board member of KEW, Inc. Dr. Kucherlapati currently serves as the Paul C. Cabot Professor of Genetics and Professor of Medicine, Harvard Medical School Director Emeritus, Harvard Medical School-Partners HealthCare Center for Personalized Genetic Medicine and Principal Investigator at the Genome Characterization Center. Dr. Kucherlapati also serves as a member of the Presidential Commission for the Study of Bioethical Issues, was a key contributor to the groundbreaking Human Genome Project and a contributing author of the published results.

Jeffrey Elton, MD

Dr. Elton is the current managing director of and global head, Predictive Health Intelligence at Accenture. He has over 20 years of experience as a global executive and consultant in the biopharmaceutical and healthcare sectors.  He was previously the global COO and strategy head of the Novartis Institutes for Biomedical Research and a partner in health care and life sciences at McKinsey & Company.

Kathy Behrens Wilsey, PhD

Prior to co-founding KEW, Inc. as CEO, Dr. Behrens Wilsey served as a managing partner of venture funds at Robertson Stephens Investments, the president and chair of the National Venture Capital Association, and a member of the President’s Council of Advisors on Science and Technology.

Call us




303 Wyman Street, Office #349
Waltham, MA 02451